Within Asahi, his focus is on virus & pathogen safety, supporting customers & internal entities technically and scientifically, and being liaison for authorities, CROs and industry consortiums of the biopharmaceuticals industry. At Biopharma-Excellence he consulted developers of new drugs in scientific & regulatory affairs during all stages to market access and is currently freelancing serving the biopharma community.